Study of chitosan/xanthan gum polyelectrolyte complexes formation, solid state and influence on ibuprofen release kinetics

2020 ◽  
Vol 148 ◽  
pp. 942-955 ◽  
Author(s):  
Ana Ćirić ◽  
Đorđe Medarević ◽  
Bojan Čalija ◽  
Vladimir Dobričić ◽  
Miodrag Mitrić ◽  
...  
2017 ◽  
Vol 157 ◽  
pp. 1874-1882 ◽  
Author(s):  
María L. Zambrano-Zaragoza ◽  
David Quintanar-Guerrero ◽  
Alicia Del Real ◽  
Elizabeth Piñon-Segundo ◽  
José F. Zambrano-Zaragoza

2016 ◽  
Vol 124 ◽  
pp. 225-229 ◽  
Author(s):  
Murat Şen ◽  
Hande Hayrabolulu ◽  
Pınar Taşkın ◽  
Murat Torun ◽  
Maria Demeter ◽  
...  

2006 ◽  
Vol 43 (2) ◽  
pp. 213-220 ◽  
Author(s):  
Gregory B. Kharas ◽  
Jeffrey R. Heiskell ◽  
Julia Herrman ◽  
Pankajkumar T. Kasudia ◽  
Peter J. Schreiber ◽  
...  

2016 ◽  
Vol 84 ◽  
pp. 161-172 ◽  
Author(s):  
Cristina-Eliza Brunchi ◽  
Maria Bercea ◽  
Simona Morariu ◽  
Mihaela Avadanei

Author(s):  
N.Phrudvish ◽  
T.Malyadri ◽  
Ch.Saibabu

The present research project aimed to develop a Control release oral Oxcarbazepine tablets by using Polymers like Tamarind gum, Xanthan gum, HPMC K4M, and HPMC K 15M were used for controlling the drug release, and the polymers are mixed in a predetermined ratio. Totally 12 formulations were prepared and evaluated for pre-compression and post-compression parameters, and all the results were found to be within the limits. From the drug and excipients compatibility studies(FT-IR) it was confirmed that the drug and excipients have any interactions. The in vitro dissolution studies revealed that the F12 formulation containing 18% of HPMC K4M & 18% of HPMC K15M controls the drug release up to 12hours. So F12 formulation was considered to be suitable for the formulation of Oxcarbazepine controlled-release tablets at 18% concentration of HPMC K4M & 18% concentration of HPMC K15M and the drug release kinetics revealed that the F12 formulation shows a super case II transport mechanism.


Sign in / Sign up

Export Citation Format

Share Document